Kailera Therapeutics Inc.
KLRA | NASDAQ
$12.86
-$0.55 (-4.10%)
At close: Oct 30, 2026, 4:00 PM ET
$12.86
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 |
|---|---|---|
Cash & Equivalents | 130.3M | 111.83M |
Short-Term Investments | 786.44M | 407.35M |
Long-Term Investments | 255.84M | 62.75M |
Other Long-Term Assets | 14.76M | 19.67M |
Receivables | 6.11M | 3.21M |
Inventory | n/a | n/a |
Other Current Assets | 395K | 360K |
Total Current Assets | 929.17M | 530.32M |
Property-Plant & Equipment | 11.65M | 12.02M |
Goodwill & Intangibles | n/a | n/a |
Total Long-Term Assets | 282.25M | 94.44M |
Total Assets | 1.21B | 624.76M |
Account Payables | 19.2M | 7.1M |
Deferred Revenue | n/a | n/a |
Short-Term Debt | 1.05M | n/a |
Other Current Liabilities | 55.01M | 5.38M |
Total Current Liabilities | 83.65M | 54.84M |
Long-Term Debt | n/a | n/a |
Other Long-Term Liabilities | 135K | 992.57M |
Total Long-Term Liabilities | 9.3M | 1B |
Total Liabilities | 92.95M | 1.06B |
Total Debt | 10.22M | 10.47M |
Book Value | 1.12B | -432.09M |
Book Value Per Share | 10.94 | -3.66 |
Common Stock | n/a | n/a |
Retained Earnings | -558.84M | -447.53M |
Comprehensive Income | -1.79M | -532K |
Shareholders Equity | 1.12B | -432.09M |
Total Investments | 1.04B | 470.1M |
Add to Watchlist
Select watchlists to add or remove KLRA